Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Obstet Gynaecol Res. 2021 Feb 15;47(4):1472–1480. doi: 10.1111/jog.14663

Figure 3. Responses in dysmenorrheic participants during menses are further broken out by IMMPACT pain relief categories.

Figure 3.

The results in Table 2 were recalculated based on reported relief to naproxen. Participants who demonstrated mild/no relief to naproxen had insignificant changes in bout duration, number of bouts, and bout intensity, while participants who demonstrated moderate/substantial response had significant changes in all measured parameters.